DCLK1-IN-1 |
DCLK1-IN-1 : Inhibitor of DCLK1, DCLK2
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| DCLK1 |
|
|
| DCLK2 |
|
Inhibitor
up to 1 uM
Selectivity
In Vitro Selectivity Assessment
Potency Assay Off-Target:
KINOMEscan profiling at a concentration of 1 μM t across a panel of 489 human kinases. DCLK1-IN-1 ex ...
In Cell Selectivity Assessment
Potency Assay Off-Target:
Kinativ: DCLK1-IN-1 significantly inhibited DCLK1, and weakly inhibited ERK5, in PATU-8988T cell lys ...
Potency Cellular
In Vitro
DCLK1
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1038/s41589-020-0506-0
DCLK2
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1038/s41589-020-0506-0
In Vivo Validations
Mouse
Dose: 10 mg/Kg
Route of delivery:
Oral
Cmax:
1014.69 ng/mL
Tmax:
1.00 h
Area Under the Curve::
5506 h/ng/ml
Bioavailability:
81%
DOI Reference: 10.1038/s41589-020-0506-0
Dose: 2 mg/Kg
Route of delivery:
Intravenous
Plasma half life:
2.09 h
Systemic clearance:
26.26 ml/min/Kg
Area Under the Curve::
1269.45 h/ng/mL
Volume of Distribution at Steady-State:
3.27 L/Kg
DOI Reference: 10.1038/s41589-020-0506-0
Negative Control Compounds
Chemical Information
| Molecular Formula | C26H28F3N7O2 |
| SMILEs | COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2CC(F)(F)F |
| InChI | InChI=1S/C26H28F3N7O2/c1-33-10-12-35(13-11-33)17-8-9-19(22(14-17)38-3)31-25-30-15-21-23(32-25)34(2)20-7-5-4-6-18(20)24(37)36(21)16-26(27,28)29/h4-9,14-15H,10-13,16H2,1-3H3,(H,30,31,32) |
| Molecular weight | 527.23 Da |
| AlogP | 0.0 |
| HBond acceptors | 9 |
| HBond donors | 1 |
| Atoms | 66 |